CIB1 deficiency results in impaired thrombosis: the potential role of CIB1 in outside-in signaling through integrin alpha IIb beta 3.
Agonist-induced inside-out signaling activates platelet integrin alpha(IIb)beta(3), rendering it to bind plasma fibrinogen (Fg). Fg binding induces outside-in signaling that culminates in platelet aggregation, leading to physiological hemostasis and pathological thrombosis. How outside-in signaling through alpha(IIb)beta(3) regulates hemostasis and thrombosis is not well understood. We have previously shown that CIB1 is involved in regulating alpha(IIb)beta(3) function.


OBJECTIVE
To determine the in vivo role of CIB1 in the process of hemostasis and thrombosis.


RESULTS
Genetic ablation of Cib1 significantly increased mouse tail bleeding time. Greater than 50% of the Cib1 null mice showed a rebleeding phenotype. Time taken for complete occlusion of carotid artery upon 10% FeCl(3)-induced injury was significantly delayed in the absence of Cib1. This was also associated with unstable thrombus formation. The inside-out signaling appears normal as ADP-, collagen- and PAR4 peptide-induced aggregation and fibrinogen binding was unaffected. The absence of Cib1 also affected the ability of platelets to spread on immobilized Fg, but not filopodia formation. Spreading could be restored in Cib1 null platelets by the addition of exogenous ADP. Outside-in signaling-dependent tyrosine phosphorylation of the integrin beta(3) subunit was significantly reduced in the absence of Cib1 as determined by Western blot analysis.


CONCLUSIONS
Using gene knockout mice, we show for the first time that lack of Cib1 results in impaired thrombosis. CIB1 regulates these processes by affecting platelet spreading, but not platelet filopodia formation. These in vivo and in vitro results clearly show that CIB1 is a key regulator of thrombosis.
Naik
M U
MU
Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA. unaik@udel.edu
Nigam
A
A
Manrai
P
P
Millili
P
P
Czymmek
K
K
Sullivan
M
M
Naik
U P
UP
D000818:Animals; D001792:Blood Platelets / Q000473:pathology; D002135:Calcium-Binding Proteins / Q000172:deficiency* / Q000502:physiology*; D048430:Cell Shape; D005340:Fibrinogen / Q000378:metabolism; D006487:Hemostasis; D051379:Mice; D018345:Mice, Knockout; D010973:Platelet Adhesiveness; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000378:metabolism*; D015398:Signal Transduction; D013927:Thrombosis / Q000209:etiology* / Q000473:pathology
D002135:Calcium-Binding Proteins; C491605:Cib1 protein, mouse; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D005340:Fibrinogen
Nature. 1999 Oct 21;401(6755):808-11
10548108
J Clin Invest. 2007 Apr;117(4):944-52
17347685
Biochem J. 1999 Sep 15;342 Pt 3:729-35
10477286
J Biol Chem. 1999 Jun 11;274(24):17257-66
10358085
Curr Opin Cell Biol. 2001 Oct;13(5):546-54
11544022
Mol Cell Biol. 2006 Nov;26(22):8507-14
16982698
Blood. 2007 Nov 1;110(9):3183-91
17664350
Blood. 2003 Aug 15;102(4):1355-62
12714504
Thromb Haemost. 2008 Nov;100(5):847-56
18989529
J Biol Chem. 1994 May 20;269(20):14738-45
7514181
J Biol Chem. 2002 Jan 18;277(3):1919-23
11704681
J Biol Chem. 1997 Feb 21;272(8):4651-4
9030514
Blood. 2006 Sep 15;108(6):1911-8
16720835
Blood. 2003 Nov 15;102(10):3629-36
12881299
J Biomed Mater Res. 1999 Jun 5;45(3):240-50
10397982
J Cell Biol. 2005 Aug 1;170(3):465-76
16061695
Mol Cell Biol. 2007 Sep;27(17):6038-52
17576811
EMBO Rep. 2006 May;7(5):506-11
16582881
J Cell Biol. 2006 Jan 16;172(2):169-75
16418530
Blood. 2004 Sep 15;104(6):1606-15
15205259
Curr Biol. 2001 Apr 17;11(8):579-86
11369202